𝔖 Bobbio Scriptorium

✦ LIBER ✦

Trial designs advance to overcome bitter pill of placebo effect

✍ Scribed by Heger, Monica

Book ID: 121426388
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 1002 KB
Volume: 19
Category: Article
ISSN: 1078-8956
DOI: 10.1038/nm1113-1353

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Using comparative effectiveness design t

Using comparative effectiveness design to improve the generalizability of bipolar treatment trials data: Contrasting LiTMUS baseline data with pre-existing placebo controlled trials

✍ Friedman, E.S.; Calabrese, J.R.; Ketter, T.A.; Leon, A.C.; Thase, M.E.; Bowden, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 266 KB

Rationale and Design of a Randomized, Do

Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study

✍ Martín J. García-González, Manuel de Mora-Martín, Silvia López-Fernández, Javier 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 220 KB

Rationale and design of a placebo-contro

Rationale and design of a placebo-controlled trial to evaluate the steroid-sparing effects of anti-IL5 monoclonal antibody (mepolizumab): Focus on cutaneous outcomes in patients with hypereosinophilic syndrome (HES)

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II—study design and rationale

✍ Rajendra H. Mehta; John H. Alexander; Robert Emery; Stephen J. Ellis; Vic Hassel 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 209 KB